[HTML][HTML] Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance

…, D Cannon, J Klena, JA Johnson, SM Owen… - Biorxiv, 2020 - ncbi.nlm.nih.gov
Since emergence of SARS-CoV-2 in late 2019, there has been a critical need to understand
prevalence, transmission patterns, to calculate the burden of disease and case fatality rates. …

The evolution of HIV testing continues

…, LG Wesolowski, SM Owen - Sexually Transmitted …, 2017 - journals.lww.com
HIV testing is a key component of HIV prevention. It is this critical clinical encounter that serves
as the starting point for diagnosing and treating persons who are infected and delivering …

Heightened HIV antibody responses in postpartum women as exemplified by recent infection assays: implications for incidence estimates

…, K Mutasa, R Ntozini, SM Owen… - AIDS research and …, 2017 - liebertpub.com
Laboratory assays that identify recent HIV infections are important for assessing impacts of
interventions aimed at reducing HIV incidence. Kinetics of HIV humoral responses can vary …

Highlights From the 2019 HIV Diagnostics Conference: Optimizing Testing for HIV, STIs, and HCV

…, AM Gaynor, LG Wesolowski, SM Owen - Sexually Transmitted …, 2020 - journals.lww.com
Since 2005, the HIV Diagnostics Conference has served as a central platform for fostering
collaborations and partnerships among attendees who are involved in all aspects of HIV …

Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure

…, SF Ethridge, L Wesolowski, SM Owen - Clinical infectious …, 2016 - academic.oup.com
Sherry Michele Owen Sherry Michele Owen … Ethridge, Laura Wesolowski, Sherry Michele
Owen, Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications …

[PDF][PDF] Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance Brandi Freeman1*, Sandra Lester2*, Lisa Mills3 …

SM Owen, BS Graham, KS Corbett… - … , Maria Morales-Betoulle1 … - scienceopen.com
Background Since the emergence of SARS-CoV-2 in late 2019, there has been a need to
identify transmission patterns, determine prevalence, and determine the true burden of …

Cloning, expression, purification and immunologic characterization of human T-lymphotropic virus type-I reverse transcriptase

SM Owen - 1999 - search.proquest.com
INFORMATION TO USERS Page 1 INFORMATION TO USERS This manuscript has been
reproduced from the microfilm master. UMI films the text directly from the original or copy …

A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection

…, J Gentry, J Lovchik, PJ Peters, SM Owen… - JAIDS Journal of …, 2019 - journals.lww.com
Background: Laboratory assays for determining recent HIV-1 infection are an important public
health tool for aiding in the estimation of HIV incidence. Some incidence assay analytes …

A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results

…, R Kassanjee, MP Busch, G Murphy, SM Owen… - Aids, 2019 - journals.lww.com
Objective: To determine the precision of new and established methods for estimating duration
of HIV infection. Design: A retrospective analysis of HIV testing results from serial samples …

Potential for High Dynamic Range Sedia Limiting Antigen Antibody Assay to Support Viral Load monitoring during Antiretroviral Therapy

JB Sempa, A Welte - medRxiv, 2023 - medrxiv.org
Introduction Viral Load (VL) monitoring is a crucial component of patient care during
antiretroviral therapy (ART) but is not routinely available in many resource-constrained settings, …